PATENT CLAIM ANALYSIS

Application Number: 16191693
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["435", "060000"]

Abstract:
The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, wherein X is CH 2  or a single bond; Y is a group of formula and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Claim (Index 8):
A method for improving cognition in a subject in need of such treatment, the method comprising:\n administering to the subject a therapeutically effective amount of a selective \u03b17 nicotinic acetylcholine receptor (nAChR) agonist, wherein the selective \u03b17 nAChR agonist is (R)-3-(6-p-tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane in free base form or in acid addition salt form.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 98.0
- Lexical Diversity: 1.25455
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15398427', '14643275', '11823312', '12262896', '12638880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.595793157158991
- 35 USC 102 Novelty (BERT): 0.498149429656035
- Combined Prediction Score: 0.5860287844086954
- Mean Citation Score: 265.025034
- Max Citation Score: 295.0835600000001
- Similarity Product: 280.28197787699713

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test